Background: Obesity is a common chronic disease, and elevated serum uric acid has been suggested to be associated with obesity. However, whether the elevation is casual or a consequence of obesity remains unclear. We performed the study to investigate the longitudinal association between serum uric acid levels and obesity.

Methods: A total of 4411 initially obesity-free subjects were followed up for 9 years. The subjects were divided into groups according to the serum uric acid quartile. Univariable and multivariable Cox regression models were used to analyze the risk factors for the development of obesity.

Results: Of the 4411 subjects, 1272 (28.8%) subjects developed obesity over 9 years of follow-up. The cumulative incidence of obesity was 21.7%, 26.4%, 31.0%, and 36.4% in quartile 1, 2, 3 and 4, respectively (p for trend < 0.001). Cox regression analyses indicated that serum uric acid levels were independently and positively associated with the risk of incident obesity.

Conclusions: Our longitudinal study demonstrated that high serum uric acid levels increase the risk of obesity.

Download full-text PDF

Source
http://dx.doi.org/10.7754/Clin.Lab.2017.170311DOI Listing

Publication Analysis

Top Keywords

serum uric
24
uric acid
24
acid levels
16
risk obesity
8
cox regression
8
obesity
7
serum
6
acid
6
uric
5
levels
4

Similar Publications

Iontophoresis-driven transdermal drug delivery system based on porous microneedles for hyperuricemia treatment.

Int J Pharm

January 2025

School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China; International Scientific and Technological Cooperation Base of Intelligent Biomaterials and Functional Fibers, Hangzhou 310018, China; Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, PR China. Electronic address:

An iontophoresis-driven porous microneedles (IPMNs) system has been developed for hyperuricemia management, which can be effectively prolong the anti-hyperuricemia effect. Porous microneedles (PMNs) with good biocompatibility, high porous volume, and excellent substance exchange capacity were firstly prepared for drug transdermal delivery and active iontophoresis.In vitro experiments showed that the transdermal delivery efficiency of anti-hyperuricemia drug (Allopurinol, AP) could be controlled using the iontophoresis current of IPMNs system.

View Article and Find Full Text PDF

Background: Primary hyperparathyroidism (PHPT) is associated with hypertension, left ventricular hypertrophy, and myocardial and valvular calcifications, leading to increased mortality rates. While the association between PHPT and diastolic dysfunction has been well-documented, data on systolic dysfunction and its reversal after curative parathyroidectomy (PTX) remains limited.

Purpose: To evaluate the effect of PTX on cardiovascular parameters, especially systolic dysfunction, in PHPT patients using conventional and speckle-tracking echocardiography (STE).

View Article and Find Full Text PDF

Objectives: Over 30% of people worldwide suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), a significant global health issue. Identifying and preventing high-risk individuals for MASLD early is crucial. The purpose of our study is to investigate the factors related to the development of MASLD and develop a risk prediction model for its occurrence.

View Article and Find Full Text PDF

Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products.

Phytomedicine

January 2025

National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, 100000, China. Electronic address:

Background: Hyperuricemia, a prevalent chronic metabolic disorder caused by purine metabolism disturbances, is characterized by elevated serum uric acid (UA) levels. Prolonged hyperuricemia can cause severe complications such as gout or kidney damage. However, the toxic side effects of and adverse reactions to UA-lowering drugs are becoming increasingly prominent.

View Article and Find Full Text PDF

Objectives: The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the relationship between serum urate and changes in dual-energy CT (DECT) urate volume in people with gout and stable serum urate concentrations.

Methods: Individual participant data were analysed from three studies of people with gout.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!